牛皮的治疗进展:从生物药物到新兴的口服小分子
Francesco Ferrara1, Chiara Verduci2, Emanuela Laconi3
1Pharmaceutical Department, Asl Napoli 3 Sud, Dell'amicizia Street 72, 80035 Nola, Italy.
Antibodies (Basel, Switzerland)
|September 23, 2024
概括
牛皮的治疗正在从局部发展到向生物药物和口服小分子,如JAK抑制剂. 新兴的疗法有望为这种慢性炎症状况提供更个性化和更有效的管理.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种慢性炎症性疾病,影响全球数百万人.
- 治疗已经从局部疗法发展到系统性干预,如生物药物和口服小分子.
- 目前的治疗方法面临的局限性包括成本和管理方面的挑战.
研究的目的:
- 提供当前和新兴的牛皮治疗方法的全面审查.
- 专注于生物药物,口服小分子和新的治疗策略.
- 突出针对性和以患者为中心的牛皮管理方面的进展.
主要方法:
- 对已批准和正在研究的牛皮治疗方法的文献综述.
- 对向TNF-α,IL-17,IL-12/23和IL-23.3的生物药物的分析.
- 对口服小分子的检查,包括Janus激酶 (JAK) 抑制剂.
- 在早期发展阶段探索新兴的小分子抑制剂.
主要成果:
- 生物疗法 (TNF-α,IL-17,IL-12/23,IL-23抑制剂) 显著改善了牛皮的控制和生活质量.
- 口服小分子,特别是JAK抑制剂,提供了方便和有效的向治疗选择.
- 新兴的小分子抑制剂在临床试验中显示出改善患者结果的前景.
结论:
- 牛皮治疗领域正在迅速发展,有针对性的疗法正在迅速推进.
- 生物药物和口服小分子在治疗牛皮方面取得了重大进展.
- 未来的研究重点是开发针对牛皮的个性化和更有效的治疗策略.
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
159
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
159
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K